Cargando…
Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway
BACKGROUND: Cerebral ischemia-reperfusion injury is a pivotal cause of deaths due to cerebrovascular accident. Increased research efforts are needed to reveal the mechanism underlying its aggravation or alleviation. In this study, the effects of dexmedetomidine post-conditioning on the HMGB1/TLR4/NF...
Autores principales: | Zhai, Yongyi, Zhu, Yulin, Liu, Jingying, Xie, Kun, Yu, Jingui, Yu, Lingzhi, Deng, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977611/ https://www.ncbi.nlm.nih.gov/pubmed/31912804 http://dx.doi.org/10.12659/MSM.918617 |
Ejemplares similares
-
rhHMGB1 drives osteoblast migration in a TLR2/TLR4- and NF-κB-dependent manner
por: Li, Ming-Jing, et al.
Publicado: (2016) -
Dihydromyricetin Attenuates Inflammation through TLR4/NF-kappaB Pathway
por: Jing, Nianshui, et al.
Publicado: (2019) -
Staphylococcus aureus Phenol-Soluble Modulins α1–α3 Act as Novel Toll-Like Receptor (TLR) 4 Antagonists to Inhibit HMGB1/TLR4/NF-κB Signaling Pathway
por: Chu, Ming, et al.
Publicado: (2018) -
Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
por: Jing, Nianshui, et al.
Publicado: (2021) -
Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors
por: Weng, Hui, et al.
Publicado: (2013)